ReviewFrontiers in pharmacology2020
Clinical Review: Navitoclax as a Pro-Apoptotic and Anti-Fibrotic Agent.
Nur Najmi Mohamad Anuar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
101 papers cite itlatest 60 shown
this paperpooled itcites it